Insulin-like growth factor-1 is a mediator of age-related decline of bone health status in men

References

• Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol Pathol 2001;54:311–6
   PubMedGoogle Scholar
• Bikle D, Majumdar S, Laib A, et al. The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 2001;16:2320–9
   PubMed Web of Science ®Google Scholar
• Mohan S, Baylink DJ. Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. J Endocrinol 2005;185:415–20
   PubMed Web of Science ®Google Scholar
• Langlois JA, Rosen CJ, Visser M, et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham heart study. J Clin Endocrinol Metab 1998;83:4257–62
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Kanatani M, Yamauchi M, et al. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Calcif Tissue Int 2006;78:18–24
   PubMed Web of Science ®Google Scholar
• Kim JG, Shin CS, Choi YM, et al. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Clin Endocrinol (Oxf) 1999;51:301–7
   PubMedGoogle Scholar
• Gillberg P, Olofsson H, Mallmin H, et al. Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 2002;70:22–9
   PubMed Web of Science ®Google Scholar
• Krassas G, Papadopoulou P, Koliakos G, et al. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men. Arch Androl 2003;49:191–9
   PubMed Web of Science ®Google Scholar
• Szulc P, Joly-Pharaboz MO, Marchand F, Delmas PD. Insulin-like growth factor I Is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. Calcif Tissue Int 2004;74:322–9
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Goodman-Gruen D. Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study. J Bone Miner Res 1998;13:1343–9
   PubMedGoogle Scholar
• World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a World Health Organization Study Group. In WHO Technical Report Series No 843. Geneva: World Health Organization; 1994
   Google Scholar
• Handa R, Ali Kalla A, Maalouf G. Osteoporosis in developing countries. Best Pract Res Clin Rheumatol 2008;22:693–708
   PubMed Web of Science ®Google Scholar
• Laugier P. An overview of bone sonometry. Int Congr Ser 2004;1274:23–32
   Google Scholar
• Chin KY, Soelaiman IN, Mohamed IN, et al. The effects of age, physical activity level, and body anthropometry on calcaneal speed of sound value in men. Arch Osteoporos 2012;7:135–45
   PubMedGoogle Scholar
• Chin KY, Soelaiman IN, Mohamed IN, Ngah WZ. Serum testosterone, sex hormone-binding globulin and total calcium levels predict the calcaneal speed of sound in men. Clinics 2012;67:911–6
   PubMedGoogle Scholar
• Krieg M-A, Barkmann R, Gonnelli S, et al. Quantitative ultrasound in the management of osteoporosis: the 2007 ISDN official positions. J Clin Densitom 2008;11:163–87
   PubMed Web of Science ®Google Scholar
• Chin K-Y, Soelaiman I-N, Mohamed IN, et al. Discrepancy between the quantitative ultrasound value of Malaysian men and the manufacturer's reference and the impact on classification of bone health status. J Clin Densitom 2013;16:189–95
   PubMed Web of Science ®Google Scholar
• Chin K-Y, Soelaiman I-N, Naina Mohamed I, et al. Testosterone is associated with age-related changes in bone health status, muscle strength and body composition in men. Aging Male 2012;15:240–5
   PubMed Web of Science ®Google Scholar
• Sobel M. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol 1982;13:290–321
   Google Scholar
• Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research – conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173–82
   PubMed Web of Science ®Google Scholar
• Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23:279–302
   PubMed Web of Science ®Google Scholar
• Seck T, Scheidt-Nave C, Leidig-Bruckner G, et al. Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women. Clin Endocrinol (Oxf) 2001;55:101–6
   PubMedGoogle Scholar
• He J, Rosen CJ, Adams DJ, Kream BE. Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. Bone 2006;38:826–35
   PubMed Web of Science ®Google Scholar
• Yakar S, Rosen CJ, Beamer WG, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 2002;110:771–81
   PubMed Web of Science ®Google Scholar
• Zhang M, Xuan S, Bouxsein ML, et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 2002;277:44005–12
   PubMed Web of Science ®Google Scholar
• Nakasaki M, Yoshioka K, Miyamoto Y, et al. IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone 2008;43:869–79
   PubMed Web of Science ®Google Scholar
• Tiago DM, Cancela ML, Laize V. Proliferative and mineralogenic effects of insulin, IGF-1, and vanadate in fish osteoblast-like cells. J Bone Miner Metab 2011;29:377–82
   PubMedGoogle Scholar
• Guglielmi G, de Terlizzi F. Quantitative ultrasound in the assessment of osteoporosis. Eur J Radiol 2009;71:425–31
   PubMed Web of Science ®Google Scholar
• Chin K-Y, Ima-Nirwana S. Calcaneal quantitative ultrasound as a determinant of bone health status: what properties of bone does it reflect? Int J Med Sci 2013;10:1778–83
   PubMed Web of Science ®Google Scholar
• Chin K, Ima-Nirwana S, Mohamed I, et al. Thyroid-stimulating hormone is significantly associated with bone health status in men. Int J Med Sci 2013;10:857–63
   PubMedGoogle Scholar
• Kurland ES, Rosen CJ, Cosman F, et al. Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1997;82:2799–805
   PubMedGoogle Scholar
• Ljunghall S, Johansson AG, Burman P, et al. Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J Intern Med 1992;232:59–64
   PubMed Web of Science ®Google Scholar
• Ammann P, Rizzoli R, Muller K, et al. IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats. Am J Physiol Endocrinol Metab 1993;265:E770–6
   PubMedGoogle Scholar
• Friedlander AL, Butterfield GE, Moynihan S, et al. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J Clin Endocrinol Metab 2001;86:1496–503
   PubMed Web of Science ®Google Scholar
• Statistics Department of Malaysia. Population distribution and basic demographic characteristics. Putrajaya: Statistics Department of Malaysia; 2011
   Google Scholar